Cargando…
Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
BACKGROUND/AIM: The aim of the study was to investigate whether treating haematological malignancy (HM) patients in a separate intensive care unit (ICU) would reduce ICU mortality. MATERIALS AND METHODS: HM patients treated by the same ICU team in a general medical ICU (GM-ICU) and a separate haemat...
Autores principales: | AYGENCEL, Gülbin, BOYACI DÜNDAR, Nazlıhan, TÜRKOĞLU, Melda, YEGİN, Zeynep Arzu, ÖZKURT, Zübeyde Nur, YAĞCI, Abdullah Münci |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569800/ https://www.ncbi.nlm.nih.gov/pubmed/33992040 http://dx.doi.org/10.3906/sag-2012-107 |
Ejemplares similares
-
Risk factors for ICU mortality in patients with hematological malignancies: a single-center, retrospective cohort study from Turkey
por: AYGENCEL, Gülbin, et al.
Publicado: (2022) -
Prevalence of Monoclonal B Lymphocytosis in First-Degree Relatives of Chronic Lymphocytic Leukemia Patients in Turkey
por: Demirci, Taner, et al.
Publicado: (2015) -
Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
por: Yegin, Zeynep Arzu, et al.
Publicado: (2020) -
Importance of RIFLE (Risk, Injury, Failure, Loss, and End-Stage Renal Failure) and AKIN (Acute Kidney Injury Network) in Hemodialysis Initiation and Intensive Care Unit Mortality
por: Kara, Iskender, et al.
Publicado: (2017) -
The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Yegin, Zeynep Arzu, et al.
Publicado: (2020)